Loading...
Delcath Systems, Inc.
DCTH•NASDAQ
Healthcare
Medical - Specialties
$13.26
$-0.59(-4.26%)
Delcath Systems, Inc. (DCTH) Financial Performance & Statements
Review Delcath Systems, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1701.69%
↑ 1701.69%
Operating Income Growth
67.50%
↑ 67.50%
Net Income Growth
44.66%
↑ 44.66%
Operating Cash Flow Growth
40.22%
↑ 40.22%
Operating Margin
-2.85%
↓ 2.85%
Gross Margin
87.57%
↑ 87.57%
Net Profit Margin
-27.21%
↓ 27.21%
ROE
-35.13%
↓ 35.13%
ROIC
-1.82%
↓ 1.82%
Delcath Systems, Inc. (DCTH) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Delcath Systems, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.10M | $9.56M | $7.77M | $3.14M |
| Cost of Revenue | $2.13M | $0.00 | $1.52M | $903000.00 |
| Gross Profit | $12.97M | $9.56M | $6.25M | $2.24M |
| Gross Profit Ratio | $0.86 | $1.00 | $0.80 | $0.71 |
| R&D Expenses | $2.91M | $3.87M | $3.39M | $3.70M |
| SG&A Expenses | $7.02M | $6.95M | $6.76M | $8.81M |
| Operating Expenses | $9.94M | $10.82M | $10.16M | $12.51M |
| Total Costs & Expenses | $12.06M | $10.82M | $11.68M | $13.42M |
| Interest Income | $0.00 | $113000.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $84000.00 | $199000.00 |
| Depreciation & Amortization | $69000.00 | $98000.00 | $100000.00 | $29000.00 |
| EBITDA | $10.48M | -$1.16M | -$13.56M | -$10.88M |
| EBITDA Ratio | $0.69 | -$0.12 | -$1.75 | -$3.47 |
| Operating Income | $3.04M | -$1.26M | -$3.91M | -$10.28M |
| Operating Income Ratio | $0.20 | -$0.13 | -$0.50 | -$3.27 |
| Other Income/Expenses (Net) | -$6.44M | $3.12M | -$9.83M | -$833000.00 |
| Income Before Tax | -$3.40M | $1.86M | -$13.74M | -$11.11M |
| Income Before Tax Ratio | -$0.23 | $0.19 | -$1.77 | -$3.54 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$14276.00 |
| Net Income | -$3.40M | $1.86M | -$13.74M | -$11.11M |
| Net Income Ratio | -$0.23 | $0.19 | -$1.77 | -$3.54 |
| EPS | -$0.11 | $0.06 | -$0.48 | -$0.45 |
| Diluted EPS | -$0.11 | $0.06 | -$0.48 | -$0.45 |
| Weighted Avg Shares Outstanding | $32.01M | $28.74M | $28.36M | $24.89M |
| Weighted Avg Shares Outstanding (Diluted) | $32.01M | $32.35M | $28.36M | $24.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan